Back
Salesforce Vs. Blueprint Medicines Industry Stock Comparison
Sell
49
CRM
Salesforce
Last Price:
$263.61
Seasonality Move:
10.93%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
49
Salesforce (CRM)
is a Sell
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $262.28. The Score for CRM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
CRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $262.28The current trend is relatively stagnant and CRM is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.96 | Sell |
Relative Strength Index (14 RSI): | 45.5 | Sell |
Chaikin Money Flow: | -3486133 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (259.77 - 270.93) | Sell |
Bollinger Bands (100): | (257.46 - 284.84) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.07 - 129.15) | Buy |
Bollinger Bands (100): | (85.79 - 122.45) | Buy |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 260.22 | Buy |
20-day SMA: | 266.43 | Sell |
50-day SMA: | 270.88 | Sell |
200-day SMA: | 296.63 | Sell |
8-day EMA: | 261.99 | Buy |
20-day EMA: | 264.52 | Sell |
50-day EMA: | 257.77 | Buy |
200-day EMA: | 152.29 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.38 | Buy |
20-day SMA: | 128.73 | Buy |
50-day SMA: | 119.37 | Buy |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 129.26 | Buy |
20-day EMA: | 127.9 | Buy |
50-day EMA: | 120.09 | Buy |
200-day EMA: | 103.72 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Salesforce Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |